Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / American Depositary Shares, each representing 120 ordinary shares Ordinary shares
Symbol
ADXN on Nasdaq
Shares outstanding
140,714,351
Price per share
$7.72
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
199
Total reported value
$1,855
% of total 13F portfolios
0%
Share change
-178
Value change
-$1,631
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dyer Timothy Mark 13% $147,670,424 18,208,437 Timothy Mark Dyer 20 Jun 2025

As of 30 Sep 2025, 4 institutional investors reported holding 199 shares of Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN). This represents 0% of the company’s total 140,714,351 outstanding shares.

Institutional Holders of Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 81 $625 -$309 $7.72 1
2025 Q3 199 $1,855 -$1,631 $9.25 4
2025 Q2 377 $3,463 -$95,571 $9.40 5
2025 Q1 13,111 $96,235 -$14,614 $7.34 5
2024 Q4 15,102 $105,714 +$93,193 $7.00 5
2024 Q3 1,388 $13,556 -$9,893 $9.77 3
2024 Q2 2,400 $19,728 +$16,522 $8.22 2
2024 Q1 390 $4,992 -$255,158 $12.80 1
2023 Q4 43,000 $260,150 +$260,150 $6.05 1